Tianjin Medical University Cancer Institute and Hospital: Clinical Trials & Research Profile

Academic Medical Center in Tianjin, China · Primary Specialty: Oncology and Hematology

Clinical Trial MetricVerified Public Record
Organization TypeClinical Trial Research Site
Institutional Sector & LocationAcademic Medical Center (Tianjin, China)
Primary Therapeutic AreaOncology and Hematology
Active Phase II & III Studies116 active (47 recruiting now)
Total Tracked Studies (2018 to 2026)215
Completed vs Early-Stopped Studies37 completed / 7 stopped (3.3% stop rate)
Median Closed Enrollment231 participants
Median Completed Study Duration1,180 calendar days
Physical Hospital Site Disclosure100.0% named hospital campus

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI -> · AI for Healthcare · Healthcare Price & Patent Cliff Crosswalk